chr12-122981204-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000315580.10(ARL6IP4):c.65A>T(p.Glu22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,549,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E22A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000315580.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP4 | NM_018694.4 | c.65A>T | p.Glu22Val | missense_variant | 2/6 | ENST00000315580.10 | NP_061164.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP4 | ENST00000315580.10 | c.65A>T | p.Glu22Val | missense_variant | 2/6 | 1 | NM_018694.4 | ENSP00000313422 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000524 AC: 8AN: 152776Hom.: 0 AF XY: 0.0000495 AC XY: 4AN XY: 80782
GnomAD4 exome AF: 0.0000336 AC: 47AN: 1397382Hom.: 0 Cov.: 32 AF XY: 0.0000363 AC XY: 25AN XY: 689214
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2024 | The c.434A>T (p.E145V) alteration is located in exon 2 (coding exon 2) of the ARL6IP4 gene. This alteration results from a A to T substitution at nucleotide position 434, causing the glutamic acid (E) at amino acid position 145 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at